Logo image of RLV.CA

RELEVIUM TECHNOLOGIES INC (RLV.CA) Stock Fundamental Analysis

TSX-V:RLV - TSX Venture Exchange - CA75942W1023 - Common Stock - Currency: CAD

0.02  0 (0%)

Fundamental Rating

1

Taking everything into account, RLV scores 1 out of 10 in our fundamental rating. RLV was compared to 2 industry peers in the Personal Care Products industry. RLV has a bad profitability rating. Also its financial health evaluation is rather negative. RLV does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

RLV had negative earnings in the past year.
RLV.CA Yearly Net Income VS EBIT VS OCF VS FCFRLV.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 -2M -4M -6M

1.2 Ratios

Industry RankSector Rank
ROA -25.8%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RLV.CA Yearly ROA, ROE, ROICRLV.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 -2K -4K -6K -8K -10K

1.3 Margins

Industry RankSector Rank
OM -284.66%
PM (TTM) -698.01%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RLV.CA Yearly Profit, Operating, Gross MarginsRLV.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 0 50 -50 -100 -150 -200

More info and screens

3

2. Health

2.1 Basic Checks

RLV has more shares outstanding than it did 1 year ago.
The debt/assets ratio for RLV is higher compared to a year ago.
RLV.CA Yearly Shares OutstandingRLV.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 50M 100M 150M 200M
RLV.CA Yearly Total Debt VS Total AssetsRLV.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2M 4M 6M 8M

2.2 Solvency

RLV has an Altman-Z score of -1.65. This is a bad value and indicates that RLV is not financially healthy and even has some risk of bankruptcy.
There is no outstanding debt for RLV. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -1.65
ROIC/WACCN/A
WACCN/A
RLV.CA Yearly LT Debt VS Equity VS FCFRLV.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 0 2M -2M 4M

2.3 Liquidity

RLV has a Current Ratio of 0.85. This is a bad value and indicates that RLV is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.85 indicates that RLV may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.85
Quick Ratio 0.85
RLV.CA Yearly Current Assets VS Current LiabilitesRLV.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 1M 2M 3M 4M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for RLV have decreased strongly by -122.79% in the last year.
RLV shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -69.36%.
RLV shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -15.37% yearly.
EPS 1Y (TTM)-122.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2944.29%
Revenue 1Y (TTM)-69.36%
Revenue growth 3Y-15.37%
Revenue growth 5YN/A
Sales Q2Q%-56.96%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RLV.CA Yearly Revenue VS EstimatesRLV.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 1M 2M 3M 4M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

RLV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RLV.CA Price Earnings VS Forward Price EarningsRLV.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -3.03
RLV.CA Per share dataRLV.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.01 -0.02 -0.03

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

RLV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

RELEVIUM TECHNOLOGIES INC

TSX-V:RLV (1/7/2022, 7:00:00 PM)

0.02

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap6.59M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.58
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA -3.03
EPS(TTM)-0.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS0
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -25.8%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -284.66%
PM (TTM) -698.01%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.85
Quick Ratio 0.85
Altman-Z -1.65
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-122.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2944.29%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-69.36%
Revenue growth 3Y-15.37%
Revenue growth 5YN/A
Sales Q2Q%-56.96%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A